ESSA Pharma (EPIX) - חוב לטווח ארוך להון

Efficient bio-warehouse logistics in gynecologic oncology contrast with the development of targeted prostate cancer therapy. The long-term debt financial leverage ratio helps assess the balance between these directions, and the current value of 0.00 captures the existing load. However, a cash deficit and a pipeline revision following the cessation of trials are forcing ESSA Pharma Inc. (EPIX) to deplete its remaining liquidity.

This indicator determines the ratio of a company's long-term liabilities to its equity. It measures the company's dependence on external financing with a maturity exceeding one year. By analyzing the long-term debt-to-equity ratio, an investor identifies the balance between financial stability and expansion rates. For ESSA Pharma Inc. (EPIX), such a borrowing structure is critical when financing costly oncology drug research. This allows the company to maintain the development of unique therapeutic mechanisms without the risk of an immediate loss of liquidity.